Torrentz

Torrent Contents

• Encyclopedia of Biopharmaceutical Statistics 2nd Ed. - (Malestrom)
• • Ac-As
  • • Acceptance Sampling.pdf 0 Mb
    • Active Control Trials.pdf 0 Mb
    • Adaptive Designs.pdf 0 Mb
    • Adaptive Dose-Finding Based on Efficacy-Toxicity Trade-Offs .pdf 0 Mb
    • Adjustment for Covariates.pdf 0 Mb
    • Adverse Event Reporting.pdf 0 Mb
    • Alpha Spending Function.pdf 0 Mb
    • Ames Test.pdf 0 Mb
    • Analysis of 2 K Tables .pdf 0 Mb
    • Analysis of Clustered Binary Data.pdf 0 Mb
    • Analysis of Heritability.pdf 0 Mb
    • Analysis of Repeated Measures Data with Missing Values- An Overview of Methods .pdf 0 Mb
    • Analysis of Variance.pdf 2 Mb
    • ANCOVA Approach for Premarketing Shelf Life Determination with Multiple Factors .pdf 0 Mb
    • Assay Development.pdf 0 Mb
    • Assay Validation.pdf 0 Mb
  • Ba-Ca to Ce-Cu
  • • Bayesian Methods in Meta-Analysis.pdf 0 Mb
    • Bayesian Statistics.pdf 0 Mb
    • Bayesian Two-Stage Design for Phase II Clinical Trials.pdf 0 Mb
    • Bioassay.pdf 0 Mb
    • Bioavailability and Bioequivalence.pdf 0 Mb
    • Bioinformatics.pdf 0 Mb
    • Biologics.pdf 0 Mb
    • Biopharmaceutics.pdf 1 Mb
    • Blinding.pdf 0 Mb
    • Bootstrap, The.pdf 0 Mb
    • Bracketing Design.pdf 0 Mb
    • Bridging Studies.pdf 0 Mb
    • Calibration.pdf 0 Mb
    • Canadian Health Products and Food Branch (HPFB) and Therapeutic Products Directorate (TPD).pdf 0 Mb
    • Cancer Trials.pdf 0 Mb
    • Carcinogenicity Studies of Pharmaceuticals.pdf 0 Mb
    • Carry-Forward Analysis.pdf 0 Mb
    • Case-Control Studies, Inference in.pdf 0 Mb
    • Center Weighting in Multicenter Trials.pdf 0 Mb
    • Clinical Data Management.pdf 1 Mb
    • Clinical Endpoint.pdf 0 Mb
    • Clinical Pharmacology.pdf 0 Mb
    • Clinical Trial Process.pdf 0 Mb
    • Clinical Trial Simulation.pdf 0 Mb
    • Clinical Trial Simulations for Earlier Development Phases.pdf 0 Mb
    • Clinical Trial Simulations for Later Development Phases.pdf 0 Mb
    • Clinical Trials.pdf 0 Mb
    • Cluster Trials.pdf 0 Mb
    • Clustered Study Designs- Power Analysis.pdf 0 Mb
    • Combination Drug Clinical Trial.pdf 0 Mb
    • Comparing Variabilities in Clinical Research.pdf 1 Mb
    • Confidence Interval and Hypothesis Testing.pdf 0 Mb
    • Confounding and Interaction.pdf 0 Mb
    • Content Uniformity.pdf 0 Mb
    • Contract Research Organization (CRO).pdf 0 Mb
    • Correlated Probit Model.pdf 0 Mb
    • Cost-Effectiveness Analysis.pdf 0 Mb
    • Crossover Design.pdf 0 Mb
    • Cutoff Designs.pdf 0 Mb
  • Da-Fa to Fo-In
  • • Data Mining and Biopharmaceutical Research.pdf 0 Mb
    • Data Monitoring Committees (DMC).pdf 0 Mb
    • Diagnostic Imaging.pdf 0 Mb
    • Dose Proportionality.pdf 0 Mb
    • Dose Response Analysis in Clinical Trials.pdf 0 Mb
    • Dose Response Study Design.pdf 0 Mb
    • Dropout.pdf 0 Mb
    • Drug Development.pdf 0 Mb
    • Ecologic Inference.pdf 0 Mb
    • ED50-ED90.pdf 1 Mb
    • Enrichment Design.pdf 0 Mb
    • Equivalence Trials.pdf 0 Mb
    • Ethnic Factors.pdf 0 Mb
    • Expiration Dating Period.pdf 0 Mb
    • Exploratory Factor Analysis.pdf 1 Mb
    • Extra Variation Models.pdf 1 Mb
    • Factor Analysis.pdf 0 Mb
    • Factorial Designs.pdf 1 Mb
    • Failure-Time Model.pdf 0 Mb
    • False Discovery Rate (FDR).pdf 0 Mb
    • Food and Drug Administration.pdf 0 Mb
    • Generalizability Probability in Clinical Research.pdf 0 Mb
    • Generalized Estimating Equation.pdf 0 Mb
    • Generalized Estimating Equations (GEE) Method- Sample Size Estimation.pdf 0 Mb
    • Genetic Linkage and Linkage Disequilibrium Analysis.pdf 0 Mb
    • Global Database and System.pdf 0 Mb
    • Good Clinical Practice.pdf 0 Mb
    • Good Programming Practice.pdf 0 Mb
    • Good Statistics Practice.pdf 0 Mb
    • Group Sequential Methods.pdf 0 Mb
    • Group Sequential Tests and Variance Heterogeneity in Clinical Trials.pdf 0 Mb
    • Hypotheses and False Positive Rate in Active Control Non-Inferiority Trials.pdf 0 Mb
    • Imputation in Clinical Research.pdf 0 Mb
    • Imputation with Item Nonrespondents.pdf 0 Mb
    • In Vitro Bioequivalence Testing.pdf 0 Mb
    • In Vitro Dissolution Profile Comparison.pdf 0 Mb
    • In Vitro Micronucleus Test.pdf 1 Mb
    • Individual Bioequivalence.pdf 0 Mb
    • Instrument Development and Validation.pdf 0 Mb
    • Integrated Summary Report.pdf 0 Mb
    • Intention-to-Treat Analyses (ITT).pdf 0 Mb
    • Interactive Voice Randomization System (IVRS).pdf 1 Mb
    • Interim Analysis.pdf 1 Mb
    • International Conference on Harmonization (ICH).pdf 0 Mb
    • Investigating Quality-of-Life in Clinical Trials.pdf 0 Mb
  • Ka-Mu
  • • Coefficients in Medical Research.pdf 0 Mb
    • Kaplan-Meier Estimator.pdf 1 Mb
    • Kullback-Leibler Divergence for Evaluating Equivalence.pdf 0 Mb
    • Laboratory Analyses.pdf 0 Mb
    • Latent Class Analysis.pdf 0 Mb
    • Lilly Reference Ranges.pdf 1 Mb
    • Local Influence Analysis.pdf 0 Mb
    • Logistic Regression in Three-Point Designs.pdf 0 Mb
    • Logistic Regression.pdf 1 Mb
    • Maximum Tolerable Dose for Cancer Chemotherapy.pdf 0 Mb
    • McNemar's Test.pdf 0 Mb
    • Measuring Agreement.pdf 0 Mb
    • MedDRA and Its Impact on Pharmaceutical Development.pdf 0 Mb
    • Medical Devices.pdf 0 Mb
    • Meta-Analysis of Therapeutic Trials.pdf 1 Mb
    • Microarray Gene Expression.pdf 1 Mb
    • Minimization Procedure.pdf 0 Mb
    • Minimum Effective Dose.pdf 0 Mb
    • Ministry of Health, Labour and Welfare and Pharmaceutical Administration in Japan.pdf 1 Mb
    • Missing Values in Repeated Measurement Designs.pdf 0 Mb
    • Mixed Effects Models.pdf 0 Mb
    • Modified Large Sample Method.pdf 0 Mb
    • Multicenter Trials.pdf 0 Mb
    • Multicollinearity.pdf 0 Mb
    • Multinational Clinical Trial.pdf 0 Mb
  • No-Pr
  • • Noninferiority Analysis in Active Controlled Clinical Trials.pdf 0 Mb
    • Odds Ratio.pdf 0 Mb
    • Onset of Action.pdf 0 Mb
    • Ordered Multiple Class Receiver Operating Characteristic (ROC) Analysis.pdf 0 Mb
    • Outlier Detection in Clinical Research.pdf 1 Mb
    • P-Values, Evidence and Multiplicity Considerations for Controlled Clinical Trials.pdf 0 Mb
    • P-Values.pdf 1 Mb
    • Parallel Design.pdf 0 Mb
    • Patient Compliance.pdf 0 Mb
    • Percentile Charts on Correlated Measures.pdf 0 Mb
    • Pharmacodynamic Issues.pdf 0 Mb
    • Pharmacodynamics with Covariates.pdf 1 Mb
    • Pharmacodynamics with No Covariates.pdf 0 Mb
    • Pharmacoeconomics.pdf 1 Mb
    • Phase I Cancer Clinical Trials.pdf 0 Mb
    • Placebo Effect.pdf 0 Mb
    • Population Bioequivalence.pdf 0 Mb
    • Population PK-PD Analysis.pdf 0 Mb
    • Postmarketing Adverse Drug Event Signaling.pdf 1 Mb
    • Postmarketing Surveillance.pdf 0 Mb
    • Power.pdf 0 Mb
    • Prediction Trees.pdf 0 Mb
    • Principal Component Analysis.pdf 0 Mb
    • Process Validation.pdf 1 Mb
    • Profile Analysis.pdf 0 Mb
    • Proportion of Treatment Effect.pdf 0 Mb
    • Proportional Hazards Regression Model.pdf 0 Mb
    • Protocol Development.pdf 0 Mb
  • Qt-St to Su-Zs
  • • QT Analysis.pdf 0 Mb
    • Randomization.pdf 0 Mb
    • Rank Regression in Stability Analysis.pdf 0 Mb
    • Release Targets.pdf 0 Mb
    • Reliability.pdf 0 Mb
    • Reproducibility Probability in Clinical Research.pdf 0 Mb
    • Reproductive-Developmental Studies.pdf 0 Mb
    • Response Surface Methodology.pdf 1 Mb
    • Risk Ratio Analysis.pdf 0 Mb
    • Robust Analysis for Crossover Design.pdf 1 Mb
    • ROC Curve.pdf 1 Mb
    • Sample Size Calculation Based on Nonparametric Statistics.pdf 0 Mb
    • Sample Size Calculation for Survival Data.pdf 0 Mb
    • Sample Size Determination.pdf 1 Mb
    • Sample Size Re-estimation Based on Observed Treatment Difference.pdf 0 Mb
    • Screening Design.pdf 0 Mb
    • Selection of Control in Clinical Trials.pdf 0 Mb
    • Sequential Estimation for the Additive Hazards Rate Model with Staggered Entry.pdf 0 Mb
    • Slope Approach for Assessment of Dose Proportionality-Linearity Under a Crossover Design.pdf 1 Mb
    • Spatio-Temporal Modeling.pdf 1 Mb
    • Specifications.pdf 0 Mb
    • SROC Curve.pdf 0 Mb
    • Stability Analysis for Frozen Drug Products.pdf 0 Mb
    • Stability Matrix Designs.pdf 0 Mb
    • Statistical Principles for Clinical Trials.pdf 0 Mb
    • Statistical Process Control.pdf 1 Mb
    • Statistical Significance.pdf 0 Mb
    • Statistical Tests for Biomarker Development with Applications to Genetics Data.pdf 0 Mb
    • Structural Equation Model.pdf 0 Mb
    • Stuart-Maxwell Test.pdf 0 Mb
    • Subgroup Analysis.pdf 0 Mb
    • Subject-Treatment Interaction.pdf 0 Mb
    • Survival Analysis.pdf 1 Mb
    • Testing for Qualitative Interaction.pdf 0 Mb
    • Therapeutic Equivalence.pdf 0 Mb
    • Titration Design.pdf 0 Mb
    • Toxicological Studies.pdf 1 Mb
    • Trend Estimation.pdf 0 Mb
    • Two-Stage Design- Phase II Cancer Clinical Trials.pdf 0 Mb
    • USP Tests.pdf 0 Mb
    • Vaccine Clinical Trials.pdf 1 Mb
    • Validation of Quantitative and Qualitative Assays.pdf 1 Mb
    • Validity of LOCF.pdf 0 Mb
    • Z-Score.pdf 0 Mb

Please note that this page does not hosts or makes available any of the listed filenames. You cannot download any of those files from here.
This list is automatically generated from a “.torrent” file which is simply metadata for the bittorrent protocol. You cannot download the “.torrent” file from here either. We don’t even cache it. If you are lucky the “.torrent” file might still be available on the pages where we found it. There is a list of URLs on top of this page where you might want to start your search. Those domains are completely independent; we have absolutely no control over them. Please don’t blame us if your monitor explodes.